Skip links

Amvuttra® (vutrisiran)

Full Name Amvuttra® (vutrisiran)
Drug Amvuttra
Manufacturer Alnylam Pharmaceuticals, Inc.
Route of Administration Subcutaneous
Site of Care Home or Healthcare Facility
Approved Indication Treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults
Disease Hereditary ATTR amyloidosis (hATTR) – Polyneuropathy (PN)
Therapeutic Area Neurology
Enrollment Form Link Enrollment Form
Phone Number 800-372-9581
Fax Number 877-349-7938
Product Website